Skip to main content
main-content

Zeitschrift

European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging 4/2020

Ausgabe 4/2020

Inhaltsverzeichnis ( 32 Artikel )

04.02.2020 | Interview | Ausgabe 4/2020

Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude Reubi

Vikas Prasad

01.04.2020 | Editorial | Ausgabe 4/2020

166Ho microsphere scout dose for more accurate radioembolization treatment planning

C Chiesa, M Maccauro

11.01.2020 | Editorial | Ausgabe 4/2020

Ethical principles for the application of artificial intelligence (AI) in nuclear medicine

Geoff Currie, K Elizabeth Hawk, Eric M. Rohren

01.04.2020 | Editorial | Ausgabe 4/2020

The importance of differentiating between qualitative, semi-quantitative, and quantitative imaging—close only counts in horseshoes

Richard M. Fleming, Matthew R. Fleming, William C. Dooley, Tapan K. Chaudhuri

18.10.2019 | Letter to the Editor | Ausgabe 4/2020

Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?

Sandip Basu, Rahul V. Parghane, Sharmila Banerjee

03.08.2019 | Original Article | Ausgabe 4/2020 Open Access

Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment

Karen D. Bosch, Sugama Chicklore, Gary J. Cook, Andrew R. Davies, Mark Kelly, James A. Gossage, Cara R. Baker

24.10.2019 | Original Article | Ausgabe 4/2020

18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial

Yan Li, Benedikt Schaarschmidt, Lale Umutlu, Michael Forsting, Aydin Demircioglu, Anna Katharina Koch, Ole Martin, Ken Herrmann, Hendrik Juette, Andrea Tannapfel, Jost Langhorst

07.11.2019 | Original Article | Ausgabe 4/2020

Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings

Julian Kirchner, Benedikt M. Schaarschmidt, Firas Kour, Lino M. Sawicki, Ole Martin, Johannes Bode, Stephan vom Dahl, Verena Keitel, Dieter Häussinger, Christina Antke, Christian Buchbender, Gerald Antoch, Philipp Heusch

01.04.2020 | Original Article | Ausgabe 4/2020

Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma

Hongping Xia, Jianxiang Chen, Hengjun Gao, Shik Nie Kong, Amudha Deivasigamani, Ming Shi, Tian Xie, Kam M. Hui

09.08.2019 | Original Article | Ausgabe 4/2020 Open Access

The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases

Maarten L. J. Smits, Mathijs G. Dassen, Jip F. Prince, Arthur J. A. T. Braat, Casper Beijst, Rutger C. G. Bruijnen, Hugo W. A. M. de Jong, Marnix G. E. H. Lam

10.09.2019 | Original Article | Ausgabe 4/2020

Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort

Arighno Das, Ahsun Riaz, Ahmed Gabr, Rehan Ali, Ronald Mora, Ali Al Asadi, Samdeep Mouli, Robert J. Lewandowski, Riad Salem

18.11.2019 | Original Article | Ausgabe 4/2020

The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure

Alexander S. Pasciak, Godwin Abiola, Robert P. Liddell, Nathan Crookston, Sepideh Besharati, Danielle Donahue, Richard E. Thompson, Eric Frey, Robert A. Anders, Matthew R. Dreher, Clifford R. Weiss

06.08.2019 | Original Article | Ausgabe 4/2020

Comparative dosimetry between 99mTc-MAA SPECT/CT and 90Y PET/CT in primary and metastatic liver tumors

Alexandre Jadoul, Claire Bernard, Pierre Lovinfosse, Laurent Gérard, Henri Lilet, Olivier Cornet, Roland Hustinx

01.04.2020 | Original Article | Ausgabe 4/2020

Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofenin

Kathy P Willowson, Geoffrey P Schembri, Elizabeth J Bernard, David LH Chan, Dale L Bailey

09.11.2019 | Original Article | Ausgabe 4/2020 Open Access

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

E. J. van Helden, S. G. Elias, S. L. Gerritse, S. C. van Es, E. Boon, M. C. Huisman, N. C. T. van Grieken, H. Dekker, G. A. M. S. van Dongen, D. J. Vugts, R. Boellaard, C. M. L. van Herpen, E. G. E. de Vries, W. J. G. Oyen, A. H. Brouwers, H. M. W. Verheul, O. S. Hoekstra, C. W. Menke-van der Houven van Oordt

22.11.2019 | Original Article | Ausgabe 4/2020

Evaluation of [68Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [68Ga]Ga-DOTA-NOC PET/CT

Divya Yadav, Sanjana Ballal, Madhav Prasad Yadav, Madhavi Tripathi, Frank Roesch, Chandrasekhar Bal

06.09.2019 | Original Article | Ausgabe 4/2020

Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors

Harun Ilhan, S. Lindner, A. Todica, C. C. Cyran, R. Tiling, C. J. Auernhammer, C. Spitzweg, S. Boeck, M. Unterrainer, F. J. Gildehaus, G. Böning, K. Jurkschat, C. Wängler, B. Wängler, R. Schirrmacher, P. Bartenstein

14.08.2019 | Original Article | Ausgabe 4/2020

Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE

Josephine Graf, Ulrich-Frank Pape, Henning Jann, Timm Denecke, Ruza Arsenic, Winfried Brenner, Marianne Pavel, Vikas Prasad

14.12.2019 | Original Article | Ausgabe 4/2020

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

Lisa Bodei, Mark S. Kidd, Aviral Singh, Wouter A. van der Zwan, Stefano Severi, Ignat A. Drozdov, Anna Malczewska, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric P. Krenning, Irvin M. Modlin

06.09.2019 | Review Article | Ausgabe 4/2020

Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours

Samuel Adant, Girish M. Shah, Jean-Mathieu Beauregard

24.01.2020 | Original Article | Ausgabe 4/2020 Open Access

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

Jolanta Kunikowska, Anna Zemczak, Maciej Kołodziej, Paweł Gut, Izabela Łoń, Dariusz Pawlak, Renata Mikołajczak, Grzegorz Kamiński, Marek Ruchała, Beata Kos-Kudła, Leszek Królicki

10.11.2019 | Original Article | Ausgabe 4/2020

Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety

Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal, Ranjit Kumar Sahoo, Madhavi Tripathi

01.04.2020 | Original Article | Ausgabe 4/2020

Dose escalation of an Evans blue–modified radiolabeled somatostatin analog 177Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors

Qingxing Liu, Yuejuan Cheng, Jie Zang, Huimin Sui, Hao Wang, Orit Jacobson, Zhaohui Zhu, Xiaoyuan Chen

03.01.2020 | Original Article | Ausgabe 4/2020 Open Access

Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung

Mayca Onega, Christine A. Parker, Christopher Coello, Gaia Rizzo, Nicholas Keat, Joaquim Ramada-Magalhaes, Sara Moz, Sac-Pham Tang, Christophe Plisson, Lisa Wells, Sharon Ashworth, Robert J. Slack, Giovanni Vitulli, Frederick J. Wilson, Roger Gunn, Pauline T. Lukey, Jan Passchier

09.12.2019 | Original Article | Ausgabe 4/2020 Open Access

Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)

Pauline T. Lukey, Christopher Coello, Roger Gunn, Christine Parker, Frederick J. Wilson, Azeem Saleem, Nadia Garman, Maria Costa, Stuart Kendrick, Mayca Onega, Arthur R. Kang’ombe, Allan Listanco, James Davies, Joaquim Ramada-Magalhaes, Sara Moz, William A. Fahy, Toby M. Maher, Gisli Jenkins, Jan Passchier, Richard P. Marshall

07.01.2020 | Original Article | Ausgabe 4/2020 Open Access

The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts

Sara Lundsten, Diana Spiegelberg, Nakul R. Raval, Marika Nestor

02.01.2020 | Original Article | Ausgabe 4/2020

Noninvasive PET tracking of post-transplant gut microbiota in living mice

Yanpu Wang, Chenran Zhang, Jianhao Lai, Yang Zhao, Dehua Lu, Rui Bao, Xun Feng, Ting Zhang, Zhaofei Liu

16.11.2019 | Original Article | Ausgabe 4/2020

TOPKi-NBD: a fluorescent small molecule for tumor imaging

Giacomo Pirovano, Sheryl Roberts, Thomas Reiner

27.01.2020 | Image of the Month | Ausgabe 4/2020

A case of abdominal wall percutaneous endoscopic gastrostomy site metastatic disease from primary oropharyngeal squamous cell carcinoma

S. L. Ayesa, S. F. Hain

22.10.2019 | Image of the Month | Ausgabe 4/2020

Granulomatous hepatitis masquerading as metastases on FDG PET/CT

Sayak Choudhury, Archi Agrawal, Ashish Mohite, Neha Mittal, Nilendu Purandare, Sneha Shah, Ameya Puranik, Venkatesh Rangarajan

18.11.2019 | Image of the Month | Ausgabe 4/2020

An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy

Majid Assadi, Reza Nemati, Hossein Shooli, Seyed Javad Rekabpour, Iraj Nabipour, Esmail Jafari, Ali Gholamrezanezhad, Abdullatif Amini, Hojjat Ahmadzadehfar

04.02.2020 | Correction | Ausgabe 4/2020

Correction to: A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination

Zhifeng Xu, Shaoyan Zheng, Aizhen Pan, Xiaofang Cheng, Mingyong Gao

Aktuelle Ausgaben